Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anemic chronic kidney disease
Pharma
Akebia's Vafseo wins FDA approval 2 years after rejection
Aekbia earned a second chance for its oral chronic kidney disease anemia med after appealing the agency's 2022 complete response letter.
Zoey Becker
Mar 28, 2024 9:25am
FibroGen CEO Enrique Conterno hits the exit after 3-year stint
Jul 25, 2023 2:02pm
Akebia finds new partner for oral anemia drug in Europe
May 25, 2023 10:56am
Akebia proposes new dosing for oral anemia drug amid FDA dispute
Apr 3, 2023 11:34am
Docs 'cautious' about GSK's new anemia drug: survey
Feb 9, 2023 2:52pm
After pair of losses, Ardelyx's CKD prospect finds FDA foothold
Nov 17, 2022 8:05am